Checkpoint Therapeutics buy krebskrebs
Start price
21.02.22
/
50%
€1.69
Target price
21.02.23
€2.50
Performance (%)
-70.34%
End price
22.02.23
€0.50
Summary
This prediction ended on 22.02.23 with a price of €0.50. The BUY prediction by krebskrebs for Checkpoint Therapeutics performed very badly with a performance of -70.34%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Checkpoint Therapeutics | - | - | - | - |
| iShares Core DAX® | -1.306% | -0.778% | 9.149% | 57.505% |
| iShares Nasdaq 100 | 1.979% | -2.045% | 6.569% | 90.022% |
| iShares Nikkei 225® | 0.593% | 6.713% | 31.580% | 65.481% |
| iShares S&P 500 | 1.425% | -0.477% | 3.616% | 62.099% |
Comments by krebskrebs for this prediction
In the thread Checkpoint Therapeutics diskutieren
In the thread Trading Checkpoint Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten